Sign in

Charlie Mitchell

Research Analyst at Wells Fargo & Company/mn

Charlie Mitchell is an Associate and former Investment Banking Analyst at Wells Fargo, where he specialized in Technology Equity Capital Markets covering a range of technology companies. During his tenure at Wells Fargo, he played a key role in equity capital markets transactions for clients in this sector, demonstrating strong analytical and financial modeling skills. Mitchell began his analyst career after graduating from Trinity College with a B.A. in Political Science and Government, before joining Gryphon in 2025 to focus on fundraising and investor relations. He maintains professional credentials in investment banking and has contributed to capital raising initiatives for technology firms.

Charlie Mitchell's questions to COMMUNITY HEALTH SYSTEMS (CYH) leadership

Question · Q3 2025

Charlie Mitchell, on behalf of Stephen Baxter, asked about the drivers behind the 5.6% growth in same-store revenue per adjusted admission and what Community Health Systems considers a sustainable rate for this metric.

Answer

Jason Johnson, Interim CFO, explained that approximately one-third of the 5.6% improvement in same-store net revenue per adjusted admission resulted from the Tennessee and New Mexico state-directed payment programs approved in Q2 2025, with the remainder driven by payer mix improvement, partially offset by lower acuity. Kevin Hammons, President and Interim CEO, suggested that a mid-single-digit net revenue per adjusted admission growth is sustainable, supported by Medicare and commercial rate increases, and an expected recovery in acuity as softer outpatient surgeries (e.g., orthopedic and cardiac) return.

Ask follow-up questions

Get Instant Answers from SEC Filings & Earnings Calls

Ask complex financial questions and get precise answers in seconds. Fintool scans millions of documents to surface insights beyond timely human analysis.

Search across 8,000+ companies
Access millions of SEC filings & transcripts
Get answers cited to the source
Try Fintool for Free

Trusted by leading investment firms and analysts